Synthesis of Surufatinib

Jan 5,2024

Synthesis of Surufatinib

Surufatinib is synthesised from dichloropyrimidine and hydroxyindole by substitution reaction. This process requires the participation of Surufatinib Amine.The specific synthesis steps are as follows:

Possible Approach to Surufatinib Amine

Sulfonyl chloride 358 was subjected to triethylamine with 2,2,2-trifluoroethanol (TFE) as the solvent at ambient temperature followed by hydrogenation to afford aniline 360. Next, exposure of 360 to DBU under microwave conditions led to the formation of an intermediate sulfene, which underwent nucleophilic attack by commercial diamines in which diamine 361 could furnish the desired sulfonamide 362. Although Golding and co-workers did not explicitly describe a synthesis of 362, closely related analogs were exemplified by this method using analogous substrates. It is likely that a modified approach to 362 was used on process scale, given the wide commercial availability of nitrobenzene 358 and diamine 361.

Possible Approach to Surufatinib Amine

Synthesis of Surufatinib

Substitution of dichloropyrimidine 363 with hydroxyindole 364 gave rise to diaryl ether 365, which then participated in a second substitution reaction with amine 362 under acidic conditions. This was followed by exposure to aqueous base furnishing surufatinib in 50% yield from 365.

Synthesis of Surufatinib

  • Related articles
  • Related Qustion
See also

Esaxerenone, a novel, nonsteroidal, selective mineralocorticoid receptor antagonist (MRA) discovered by Exelixis and developed by Daiichi Sankyo, was approved in Japan to treat hypertension.....

Jan 5,2024API

Voxelotor, also known as GBT440, is a relaxed-state (R-state) stabilizer of hemoglobin developed by Global Blood Therapeutics and approved by the USFDA for treating sickle cell disease.....

Jan 5,2024API